Efficacy of Imipenem/Cilastatin/ Relebactam in infections caused by Difficult-to-Treat Gram-Negative Bacteria: A Retrospective Analysis of Real-world data in Greece
The findings of this study reinforce the value of IMI/REL as an effective and well-tolerated treatment for severe GNB infections in a complex, real-world patient population. These outcomes compare favourably with published data for other new BL/BLI agents, supporting the targeted use of IMI/REL as a crucial component of modern antibiotic stewardship.
Authors
- Periklis Panagopoulos (ORCID: https://orcid.org/0000-0003-0643-1090)
- Dimitrios Papazoglou (ORCID: https://orcid.org/0000-0003-4846-2178)
- Vasileios Petrakis (ORCID: https://orcid.org/0000-0002-9065-4811)
- Maria Panopoulou (ORCID: https://orcid.org/0000-0002-9708-8920)
- Theocharis Konstantinidis (ORCID: https://orcid.org/0000-0003-4296-3414)
- Petros I. Rafailidis
- Nikoleta Babaka
Institutions
- Democritus University of Thrace (GR)
Publication Details
- Journal
- Infezioni in Medicina
- Published
- 2025-12-01
- DOI
- https://doi.org/10.53854/liim-3304-7
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00